ストックスクリーナーアプリを入手
2.045
5.32%
-0.115
前日終値:
$2.16
開ける：
$2.1725
24時間の取引高:
55,888
Relative Volume:
0.03
時価総額：
$16.74M
収益：
-
当期純損益:
$-7.72M
株価収益率:
-0.7748
EPS:
-2.6394
ネットキャッシュフロー:
$-6.25M
1週間 パフォーマンス:
-14.22%
1か月 パフォーマンス:
-8.14%
6か月 パフォーマンス:
-15.50%
1年 パフォーマンス:
-54.70%
1日の値動き範囲:
$1.935
$2.1725
1週間の範囲:
$1.935
$2.40
52週間の値動き範囲:
$1.55
$5.59
Edesa Biotech Inc Stock (EDSA) Company Profile
EDSA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
2.045 | 16.74M | 0 | -7.72M | -6.25M | -2.6394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Edesa Biotech Inc (EDSA) 最新ニュース
Edesa Biotech Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView
Edesa Biotech (EDSA) to Release Quarterly Earnings on Friday - Defense World
Edesa Biotech to Present at 2024 Bloom Burton Healthcare Investor Conference - TipRanks
Edesa Biotech to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference in Toronto - Nasdaq
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference - GlobeNewswire
Edesa Biotech Showcases Immuno-Inflammatory Pipeline at Bloom Burton Healthcare Conference - Stock Titan
Edesa Biotech (NASDAQ:EDSA) Shares Up 3% – Time to Buy? - Defense World
Healthcare Veteran Returns to NeuPath as President, Armed with Ambitious Expansion Plan - Stock Titan
Edesa Biotech secures $15 million for clinical program - MSN
Edesa Biotech (NASDAQ:EDSA) and Earth Science Tech (OTCMKTS:ETST) Head-To-Head Review - Defense World
Edesa Biotech says Peter Weiler to succeed Stephen Lemieux as CFO - MSN
Nuvectis Pharma (NASDAQ:NVCT) and Edesa Biotech (NASDAQ:EDSA) Critical Analysis - Defense World
Edesa Biotech Announces Chief Financial Officer Transition - GlobeNewswire
Edesa Biotech announces CFO transition - MSN
Edesa Biotech names Peter Weiler as new CFO By Investing.com - Investing.com South Africa
Edesa Biotech (EDSA) Shares Drop After New CFO Announcement - GuruFocus
Edesa Biotech Appoints New CFO Amid Leadership Change - TipRanks
Edesa Biotech names Peter Weiler as new CFO - Investing.com
Edesa Biotech Hires Peter Weiler From Exzell Pharma to be New CFO - marketscreener.com
Edesa Biotech, Inc. Announces Chief Financial Officer Changes, Effective May 1, 2025 - MarketScreener
HC Wainwright Comments on Edesa Biotech Q2 Earnings - Defense World
HC Wainwright Reiterates “Buy” Rating for Edesa Biotech (NASDAQ:EDSA) - Defense World
H.C. Wainwright maintains $21 target on Edesa Biotech shares By Investing.com - Investing.com Australia
H.C. Wainwright maintains $21 target on Edesa Biotech shares - Investing.com India
Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential - The Globe and Mail
Edesa Biotech completes US$15 million private placement - Fasken
You Won't Believe What Nvidia CEO Jensen Huang Just Said - The Globe and Mail
Edesa Biotech files to sell 7.81M common shares for holders - MSN
Nvidia Stock Isn’t So Magnificent Anymore. Is It Time to Sell Shares Now? - The Globe and Mail
Zacks Small Cap Boosts Earnings Estimates for Edesa Biotech - Defense World
EDSA: Raises 15 Million to Advance EB06 - Smartkarma
EDSA: Raises $15 Million to Advance EB06… - Yahoo Finance
Biotech Stocks To Keep An Eye OnFebruary 13th - MarketBeat
Biotech Stocks To Keep An Eye On – February 13th - Defense World
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results - GlobeNewswire
Edesa Biotech Advances Vitiligo Treatment Amidst Solid Financial Backing - TipRanks
Edesa Biotech Inc. (EDSA) reports earnings - Quartz
Edesa Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Edesa Biotech, Inc. SEC 10-Q Report - TradingView
Edesa Biotech Reports Q1 2025 Financial Results and Updates on EB06 Development for Vitiligo Treatment - Nasdaq
Edesa's Q1 Report Reveals Major Vitiligo Drug Progress: $15M Cash Injection Fuels FDA Push - StockTitan
US Penny Stocks To Watch In February 2025 - Simply Wall St
Edesa Biotech secures $15 million for clinical program By Investing.com - Investing.com Nigeria
Novartis to acquire Anthos Therapeutics for up to $3.1 billion - MSN
Edesa Biotech, Inc. announced that it has received $14.999992 million in funding from Velan Capital Investment Management LP and another investor - Marketscreener.com
H: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Edesa Biotech Inc (EDSA) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Dow Jumps Over 100 Points; Deere Posts Upbeat Earnings - Benzinga
Stock market news: Moleculin Biotech +583.33%, Cloudastructure +105.68% among top gainers during midday trading - Business Upturn
Edesa Biotech Inc (EDSA) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):